Bates SE - Search Results

1

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma.

Piekarz RL, Frye R, Prince HM, Kirschbaum MH, Zain J, Allen SL, Jaffe ES, Ling A, Turner M, Peer CJ, Figg WD, Steinberg SM, Smith S, Joske D, Lewis I, Hutchins L, Craig M, Fojo AT, Wright JJ, Bates SE. Piekarz RL, et al. Among authors: bates se. Blood. 2011 Jun 2;117(22):5827-34. doi: 10.1182/blood-2010-10-312603. Epub 2011 Feb 25. Blood. 2011. PMID: 21355097 Free PMC article. Clinical Trial.

2

Various methods of analysis of mdr-1/P-glycoprotein in human colon cancer cell lines.

Herzog CE, Trepel JB, Mickley LA, Bates SE, Fojo AT. Herzog CE, et al. Among authors: bates se. J Natl Cancer Inst. 1992 May 6;84(9):711-6. doi: 10.1093/jnci/84.9.711. J Natl Cancer Inst. 1992. PMID: 1349044

3

Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrate.

Bates SE, Currier SJ, Alvarez M, Fojo AT. Bates SE, et al. Biochemistry. 1992 Jul 21;31(28):6366-72. doi: 10.1021/bi00143a002. Biochemistry. 1992. PMID: 1352990

4

Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines.

Lai GM, Moscow JA, Alvarez MG, Fojo AT, Bates SE. Lai GM, et al. Among authors: bates se. Int J Cancer. 1991 Nov 11;49(5):688-95. doi: 10.1002/ijc.2910490511. Int J Cancer. 1991. PMID: 1682279

5

P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines.

Lai GM, Chen YN, Mickley LA, Fojo AT, Bates SE. Lai GM, et al. Among authors: bates se. Int J Cancer. 1991 Nov 11;49(5):696-703. doi: 10.1002/ijc.2910490512. Int J Cancer. 1991. PMID: 1682280

6

Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression.

Murphy LD, Herzog CE, Rudick JB, Fojo AT, Bates SE. Murphy LD, et al. Among authors: bates se. Biochemistry. 1990 Nov 13;29(45):10351-6. doi: 10.1021/bi00497a009. Biochemistry. 1990. PMID: 1979752

7

Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation.

Bates SE, Mickley LA, Chen YN, Richert N, Rudick J, Biedler JL, Fojo AT. Bates SE, et al. Mol Cell Biol. 1989 Oct;9(10):4337-44. doi: 10.1128/mcb.9.10.4337-4344.1989. Mol Cell Biol. 1989. PMID: 2573830 Free PMC article.

8

Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas.

Wilson WH, Chabner BA, Bryant G, Bates S, Fojo A, Regis J, Jaffe ES, Steinberg SM, Goldspiel BR, Cheson BD, et al. Wilson WH, et al. J Clin Oncol. 1995 Feb;13(2):381-6. doi: 10.1200/JCO.1995.13.2.381. J Clin Oncol. 1995. PMID: 7531220 Clinical Trial.

9

Molecular targets in the National Cancer Institute drug screen.

Bates SE, Fojo AT, Weinstein JN, Myers TG, Alvarez M, Pauli KD, Chabner BA. Bates SE, et al. J Cancer Res Clin Oncol. 1995;121(9-10):495-500. doi: 10.1007/BF01197759. J Cancer Res Clin Oncol. 1995. PMID: 7559726 Review. No abstract available.

10

Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy.

Wilson WH, Jamis-Dow C, Bryant G, Balis FM, Klecker RW, Bates SE, Chabner BA, Steinberg SM, Kohler DR, Wittes RE. Wilson WH, et al. Among authors: bates se. J Clin Oncol. 1995 Aug;13(8):1985-94. doi: 10.1200/JCO.1995.13.8.1985. J Clin Oncol. 1995. PMID: 7636539 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

407 results

Search Page